Abstract: The present relates to an autologous bioadhesive sealant composition, or fibrin glue prepared by a two-phase method, wherein all of the blood components for the bioadhesive sealant are derived from a patient to whom the bioadhesive sealant will be applied. A platelet rich plasma and a platelet poor plasma are formed by centrifuging a quantity of anticoagulated whole blood that was previously drawn from the patient. In one embodiment the platelet rich plasma is divided into two portions. In phase one, a compound that reverses the effect of the anticoagulant is added to the first portion and a clot is allowed to form. The clot is then triturated, and the resulting, serum containing autologous thrombin is collected. In phase two, the serum obtained from phase one is mixed with the second portion of the-platelet rich plasma to form the bioadhesive sealant of the invention.
Type:
Grant
Filed:
June 23, 2005
Date of Patent:
November 6, 2012
Assignee:
Ateriocyte Medical Systems, Inc.
Inventors:
Robert F. Baugh, Lisa M. Lim, Julie S. Johnston, John G. Rivera
Abstract: A system and method for integrating enterprise services repository (ESR) events into business process model and notation (BPMN) processes are disclosed. An instance of a message event definition is created based on an ESR event imported into a modeling infrastructure and which can be used as an event of a BPMN process modeled using the modeling infrastructure. The instance of the message event definition is provided as a trigger of the event of the BPMN process for a business process application. The instance of the message event definition is associated with an instance of the event of the BPMN process to link the enterprise service repository event to the BPMN process.